Oncospace (now part of Sun Nuclear, a Mirion Medical company)
About Oncospace (now part of Sun Nuclear, a Mirion Medical company)
Oncospace, now integrated into Sun Nuclear (a Mirion Medical company), is a healthcare AI company that developed cloud-based, AI-powered solutions for the radiation oncology community. Its core mission is to optimize patient outcomes and enhance the precision and efficiency of radiation therapy planning through data-driven, physician-centric tools. Oncospace leverages artificial intelligence and machine learning to analyze extensive clinical treatment plans, enabling the derivation of achievable, best-practice dosimetry goals for plan optimization and evaluation.
The company’s offerings include a Treatment Planning Conversion solution, known as Gateway, which facilitates the migration of patient archives from systems like Philips Pinnacle to modern treatment planning solutions such as RaySearch RayStation and Varian Medical Systems® Eclipse. Additionally, Oncospace provides a Predictive Plan Quality and Feasibility solution that analyzes thousands of clinical treatment plans to guide oncologists and dosimetrists in crafting optimal, personalized treatment plans while minimizing side effects. This technology aims to provide consistency, built-in safety checks, and the ability to compare results, ultimately elevating the standard of care globally, even for smaller practices.
Focus Areas
Business Intelligence
| Key Investors | NIH |
| Partnerships | Originated from Johns Hopkins University; Sun Nuclear partners with various industry vendors and scientific associations. |
| Acquisitions | Acquired by Sun Nuclear (a Mirion Medical company) on April 30, 2025. |
| Technology | Cloud-based, AI and machine learning technologies, data-mining system, leverages clinical treatment plans, Parquet database in the cloud, integrates with Varian Medical Systems® Eclipse™ and RaySearch RayStation® |
| FDA Clearances | 1 (Plan AI software for prostate, head and neck, thoracic, abdomen, and pelvis radiotherapy) cleared products (estimated) |
What Physicians Need to Know
For physicians, Oncospace (now Plan AI) acts as an AI 'assistant' that provides a powerful starting point for treatment planning, predicting the best achievable plan before the process even begins. This leads to faster, more consistent, and patient-centered plans, helping to ensure high-quality, safe treatment while significantly streamlining the planning workflow. It helps reduce variability, improve consistency, and accelerate workflows while maintaining clinical goals and quality standards. The system is designed to raise the level of quality for all practices, providing consistency, built-in safety checks, and the ability to compare results, even for smaller practices. With FDA approval for multiple cancer types, it offers validated models from day one, eliminating the need for time-consuming in-house model building. This provides confidence in treatment plan quality and can reduce uncertainty during physician review.
Oncospace solutions are now integrated into the Sun Nuclear brand, a Mirion Medical company, expanding their radiation therapy quality assurance digital strategy. The Plan AI software is designed to complement existing treatment planning systems (TPS), with seamless script-based integration that preserves optimization workflows. It specifically works with Varian Medical Systemsu00ae Eclipseu2122 and RaySearch RayStationu00ae through scripting to create AI-guided optimization objectives. Additionally, the 'Gateway' offering supports the migration of patient data from Philips Pinnacle to these modern TPS in DICOM format.
What the Web Says
Oncospace, now part of Sun Nuclear (a Mirion Medical company), offers cloud-based, AI-powered solutions for radiation oncology, aiming to optimize patient treatment outcomes. Sun Nuclear focuses on independent, integrated quality management solutions for radiation therapy and diagnostic imaging. Employee reviews for Sun Nuclear indicate a mixed sentiment, with some praising the work environment and benefits, while others express concerns about management and opportunities for advancement.
Overall: MixedStrengths
- AI-powered solutions for optimizing radiation oncology treatment outcomes (Oncospace).
- Focus on patient safety and independent quality management in radiation therapy and diagnostic imaging (Sun Nuclear).
- Good work-life balance reported by some employees.
- Phenomenal benefits and decent pay according to some employees.
- Friendly coworkers and a great working environment.
- Opportunity to learn new products and technology.
Limitations
- Lack of quality management and support from upper management.
- Limited opportunities for advancement due to a narrow field.
- Concerns about incorrect job titles to save company money.
- Toxic environment and aggressive micromanagement reported by some.
- Unorganized and issues with favoritism in some Mirion departments.
- Some employees feel undermined and that good software development processes are destroyed by contractors.
Based on reviews from: Indeed.com, G2.com, Reddit.com, Business Wire, 01net.com, Mirion Technologies
Last updated: 2026-07-19
Videos
News, demos, and interviews about Oncospace (now part of Sun Nuclear, a Mirion Medical company).
Videos load interactively. If none appear, search YouTube for Oncospace (now part of Sun Nuclear, a Mirion Medical company) →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]